A patient with breast cancer was given a dose of radiation along with chemotherapy and was apparently cured of the tumor. After five years, a tumor was noticed in the patient's lungs, but the doctors confirmed that it was derived from cells of the mammary gland. The following possibilities were suggested by the doctor. A. Bacterial infection, after radiation, led to development of the tumors in the lungs. B. Migration of residual chemo-resistant cells from the mammary gland resulted in tumors in the lungs. C. Epithelial-to-mesenchymal transition had occurred in the lungs. D. Cells in the lungs were induced to become a tumor after chemotherapy and from factors secreted by mammary cells: Which of the following is correct? (1) B and D (2) Only B (3) A and B (4) A and C

29. Cellular level of tumour suppressor protein p53 is maintained by the ubiquitin ligase protein, Mdm2. Over expression of Mdm2 was found to convert a normal cell into cancer cells by
destabilizing p53 .Another protein p19ARF inhibits the activity of Mdm2 thus stabilizing p53. Loss of p19ARF function also converts normal cells into cancer cells. Based on the above information, which one of the following statements is correct?
(1) Both MDM2 and p19ARF are oncogenes.
(2) Both MDM2 and p19ARF are tumour suppressor genes.
(3) MDM2 is an oncogene and p19ARF is tumour suppressor gene.
(4) p19ARF is oncogenes and MDM2 is a tumour suppressor gene.

 

The correct statement is:

(3) MDM2 is an oncogene and p19ARF is a tumor suppressor gene.

Explanation

  • MDM2 is classified as an oncogene because it negatively regulates the tumor suppressor p53 by targeting it for ubiquitin-mediated degradation. Overexpression of MDM2 destabilizes p53, reducing its tumor suppressor functions and thereby promoting cancer development.​

  • p19ARF functions as a tumor suppressor gene because it inhibits MDM2 activity, leading to stabilization and activation of p53. Loss of p19ARF results in unchecked MDM2 activity, decreased p53 stability, and increased susceptibility to tumorigenesis.​

This regulatory axis between MDM2 and p19ARF is critical in controlling p53 levels and function in cells, impacting cancer progression.


6 Comments
  • Kirti Agarwal
    October 30, 2025

    Statement 3 is correct

  • Kajal
    November 6, 2025

    Option 3

  • Sonal Nagar
    November 9, 2025

    MDM2 is an oncogene and p19ARF is tumour suppressor gene.

  • Santosh Saini
    November 15, 2025

    MDM2 is an oncogene and p19ARF is a tumor suppressor gene

  • Aafreen khan
    November 15, 2025

    MDM2 is an oncogene and p19ARF is a tumor suppressor gene

  • Sakshi Kanwar
    November 18, 2025

    MDM2 is an oncogene and p19ARF is a tumor suppressor gene

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest Courses